Searched for
BIOPHARMACEUTICAL SUPPLY CHAIN
NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...- Why the world is betting on China again, and what India must do about itChina's business environment prioritizes market share with strong government backing. The nation has shifted to high-quality, high-speed pr...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- US stock market futures today: Why are Dow Jones and S&P 500 in red while Nasdaq turns green today? Dow drops 280 points as oil tops $120— can AI spending offset rising inflation fears and Fed uncertainty?Why are Dow Jones and S&P 500 in red while Nasdaq turns green today? The US stock market futures today are sending a sharp, layered signal....
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- China pulls ahead in biologics race, forcing Indian drugmakers to rethink strategyIndia's drug companies face a tough race in the global biologics market. China is quickly becoming a leader in biotech supply chains. India...
- Government urges pharma sector to anchor global supply chains via quality, innovationUnion Minister J P Nadda urged India's pharmaceutical industry to lead global supply chains with quality and innovation. India is embracing...
- US NSA Sullivan highlights challenges posed by China's "predatorial industrial strategies" and importance of India-US collaborationDuring his visit to India, the US National Security Advisor emphasized the importance of US-India collaboration to tackle China's predatori...
- 50% of 8 billion vaccine doses worldwide manufactured in India: Union health secretaryIndia has manufactured half of the world's vaccine doses in the past year, says Union Health Secretary Punya Salila Srivastava. The country...
- Next leg of pharma sector growth necessitates skill advancement, innovation: Eco SurveyEconomic Survey 2024: The domestic pharmaceutical industry in India needs skill advancement, innovation, and a robust supply chain to meet ...
- Budget 2024: A shot in the arm for green energy initiativesIn the Interim Budget, Finance Minister Nirmala Sitharaman introduced financial assistance for the procurement of biomass aggregation machi...
- DCGI grants Emergency Use Authorization to Gennova biopharma's Omicron-specific covid boosterThe mRNA-based vaccine was developed by Gennova Biopharmaceuticals using the indigenous platform technology, and supported under the Missio...
- Indian pharma firm Granules opens packaging facility in US' VirginiaGranules, which was one of the first Indian pharmaceutical companies that received FDA authorization to export to the United States, has in...
- Samsung to invest $356 billion over five years in strategic sectorsSouth Korea's top conglomerate said on Tuesday the investments through 2026 are expected to help Samsung drive long-term growth in strategi...
- AstraZeneca antibody drug important as preventative COVID-19 therapy: ExecutiveThe experimental monoclonal antibodies therapy, called AZD7442, reduced the risk of severe COVID-19 or death by half in non-hospitalised pa...
- VAV Lifesciences to supply key COVID vaccine ingredient to Pfizer, ModernaMumbai-based VAV Lifesciences is the only domestic firm in the COVID-19 vaccine supply chain with this crucial ingredient. It can thus can ...
- Biocon Biologics approves primary equity investment by ADQ worth Rs 555 croreAs per the terms of the proposed agreement, ADQ will invest Rs 555 Crore for a 1.80 per cent minority stake in the biosimilar business, val...
Load More
